 |
|
Rate of secondary cancers increases over years after treatment for childhood leukemia
March 21, 2007Survivors of acute lymphoblastic leukemia have a significantly increased risk of secondary cancers developing over 30 years after leukemia treatment when compared to the general population, according to a study in the March 21 issue of JAMA.
Acute lymphoblastic leukemia is the most common cancer in children and adolescents, with almost 4,000 new cases diagnosed in the United States each year. It is also one of the most curable pediatric cancers: survival rates for patients who receive contemporary treatments now exceed 80 percent, and most of these survivors are cured (no evidence of disease for at least 10 years). "Accordingly, characterization of long-term outcomes in acute lymphoblastic leukemia patients who remain in first complete remission for at least a decade has assumed increasing importance, especially in view of the long life expectancy of this survivor population." But little is known about the incidence of secondary tumors or cancer after 15 to 20 years in children and adolescents who were treated for acute lymphoblastic leukemia.
Nobuko Hijiya, M.D., of St. Jude Children's Research Hospital, Memphis, Tenn., and colleagues conducted a study to estimate the long-term (30-year) cumulative incidence of secondary neoplasms (cancers) in 2,169 children and adolescents treated for acute lymphoblastic leukemia between 1962 and 1998 at St. Jude Children's Research Hospital. The patients had achieved complete remission and had a median (mid-point) follow-up time of 18.7 years (range, 2.4-41.3 years).
The researchers found that among the 1,290 patients who remained in complete remission, 123 (9.5 percent) developed a secondary neoplasm as their first event. The cumulative incidence of secondary neoplasms in all patients as the first event after complete remission was 4.17 percent at 15 years, increasing to 5.37 percent at 20 years and to 10.85 percent at 30 years. "The relatively rapid increase in incidence at 20 years after complete remission can be attributed largely to the late development of meningiomas [a tumor near the brain and spinal cord] and basal cell carcinomas," the authors write.
When meningiomas and basal cell carcinomas were excluded, the overall cumulative incidence was 3.99 percent at 15 years and 6.27 percent at 30 years, representing a 13.5-fold increase in overall risk compared with the general population.
The cumulative incidence of each tumor type at 30 years was 2.19 percent for myeloid (related to bone marrow) malignancy, 0.17 percent for lymphoma, 3.00 percent for brain tumor, 4.91 percent for carcinoma, and 0.57 percent for sarcoma.
"In conclusion, the cumulative incidence of secondary neoplasm after treatment for childhood acute lymphoblastic leukemia does not attain a plateau at 15 to 20 years but continues to increase over 30 years. Although the majority of these late-occurring secondary neoplasms are low-grade tumors such as meningioma and basal cell carcinoma, the health care issues they raise may be critical. The risk for high-grade tumors, especially carcinomas, significantly exceeds the risk in the general population, underscoring the need for continued careful follow-up of acute lymphoblastic leukemia survivors," the authors write.
JAMA and Archives Journals
The researchers found that among the 1,290 patients who remained in complete remission, 123 (9.5 percent) developed a secondary neoplasm as their first event. The cumulative incidence of secondary neoplasms in all patients as the first event after complete remission was 4.17 percent at 15 years, increasing to 5.37 percent at 20 years and to 10.85 percent at 30 years. "The relatively rapid increase in incidence at 20 years after complete remission can be attributed largely to the late development of meningiomas [a tumor near the brain and spinal cord] and basal cell carcinomas," the authors write.
When meningiomas and basal cell carcinomas were excluded, the overall cumulative incidence was 3.99 percent at 15 years and 6.27 percent at 30 years, representing a 13.5-fold increase in overall risk compared with the general population.
The cumulative incidence of each tumor type at 30 years was 2.19 percent for myeloid (related to bone marrow) malignancy, 0.17 percent for lymphoma, 3.00 percent for brain tumor, 4.91 percent for carcinoma, and 0.57 percent for sarcoma.
"In conclusion, the cumulative incidence of secondary neoplasm after treatment for childhood acute lymphoblastic leukemia does not attain a plateau at 15 to 20 years but continues to increase over 30 years. Although the majority of these late-occurring secondary neoplasms are low-grade tumors such as meningioma and basal cell carcinoma, the health care issues they raise may be critical. The risk for high-grade tumors, especially carcinomas, significantly exceeds the risk in the general population, underscoring the need for continued careful follow-up of acute lymphoblastic leukemia survivors," the authors write.
JAMA and Archives Journals
Childhood Leukemia Current Events and Childhood Leukemia News RSSAmerican Dietetic Association Releases Updated Position Paper Promoting and Supporting Breastfeeding
The American Dietetic Association has released an updated position paper on breastfeeding that details health benefits for both infants and mothers and encourages promotion of breastfeeding whenever possible.
New Drug for Children with High-Risk Leukemia
Each year, approximately 4,500 children in America are diagnosed with leukemia, according to the Leukemia and Lymphoma Society. A potentially deadly cancer of the blood, it is the most common cancer in children.
Comprehensive look at rare leukemia finds relatively few genetic changes launch disease
The most comprehensive analysis yet of the genome of childhood acute myeloid leukemia (AML) found only a few mistakes in the genetic blueprint, suggesting the cancer arises from just a handful of missteps.
Ask permission to use newborn data, parents say
More than three-quarters of parents would be willing to permit the use of their children's newborn screening samples for research purposes if their permission were obtained beforehand, a University of Michigan survey shows.
MGH study identifies first molecular steps to childhood leukemia
A Massachusetts General Hospital (MGH)-based research team has identified how a chromosomal abnormality known to be associated with acute lymphoblastic leukemia (ALL) - the most common cancer in children - initiates the disease process.
Shilatifard Lab Identifies New Role for Factor Critical to Transcription
The Stowers Institute's Shilatifard Lab has identified a new role for the elongation factor ELL in gene transcription by RNA polymerase II (Pol II) - the enzyme that synthesizes messenger RNA to carry genetic information from DNA to the protein-synthesizing machinery of the cell.
Developing cancer treatments directed at critical developmental pathway
Researchers from the University of Pennsylvania School of Medicine and colleagues discovered that the Notch signaling pathway, which determines the development of many cell types, and is also implicated in some cancers, is not universally essential for the maintenance of stem cells.
Childhood leukemia survivors struggle with long-term comorbidities
Survival rates of childhood cancers, especially leukemia, have improved greatly in the past three decades, but survivors of this disease still seem to face many health and lifestyle challenges as young adults.
Unique role for blood formation gene identified
All blood cell production in adults depends on the steady work of a vital gene that if lost results in early bone marrow failure, Dartmouth Medical School cancer geneticists have found.
Research shows cord blood comparable to matched bone marrow
University of Minnesota researchers report that umbilical cord blood transplants may offer blood cancer patients better outcomes than bone marrow transplants, according to an analysis of outcome data performed at the Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee.
More Childhood Leukemia Current Events and Childhood Leukemia News Articles
 |
Childhood Leukemia: A Guide for Families, Friends and Caregivers (3rd Edition) by Nancy Keene (Author) This most complete parent guide available covers not only detailed and precise medical information about leukemia and the various treatment options, but also day-to-day practical advice on how to cope with procedures, hospitalization, family and friends, school, social and financial issues, communication, feelings, and, if therapy is not successful, the difficult issues of death and bereavement. Woven among the medical details and the practical advice are the voices of parents and children who have lived with leukemia and its treatments. As many parents have already found, advice from "veteran" parents can be a lifeline.This third edition contains significant updates to the information on treatments, chemotherapy drugs, bone marrow transplants, coping with side effects, and resources. It... |
 |
The Cure of Childhood Leukemia: Into the Age of Miracles by John M.D Laszlo (Author) Half a decade ago, childhood leukaemia was always fatal. Though the number of new cases remains largely unchanged, what has changed is the outcome. Today, over 75 per cent of children with leukaemia can be cured. No-one can put a specific date on the cure of leukaemia or say which child was the first to live rather than die. Dr John Laszlo tells the story of this victory over cancer through the voices of nine doctors and researchers. In a counterpoint of voices from patients and parents, he recreates the tense world of hospital wards of desperately ill children, the bitter days when new therapies ended in relapses, and then the cautious hope as remissions became longer and longer. |
 |
Childhood Leukemias by Ching-Hon Pui (Editor) Childhood leukemias represent nearly one third of all cancers in children and present a unique challenge to oncologists, pediatricians, hematologists, and other health professionals. Ching-Hon Pui has assembled an expert team of authors to develop the most comprehensive, clinically-oriented, and authoritative reference dedicated to these diseases. The volume moves from the laboratory bench to the patient bedside in four easily-accessible sections. Fully referenced and up-to-date, it is an absolute 'must-have' for any physician or investigator who deals with leukemias in childhood. |
 |
My Son... My Hero: The True Story of Michael James' Brave Fight Against Childhood Leukemia by Kevin Smith (Author) My Son, My Hero is the true account of 7 year old Michael James' brave battle with childhood cancer. It follows the story through his father Kevin's eyes. Included are all of the highs and lows that are commonplace when battling cancer. All facts are included, from the time of Michael's birth, to his first diagnosis at age 4, through his 2 year remission, then relapse and the road to bone marrow transplant. This book provides insight firsthand from the father who was with Michael constantly, is 100% true and is not embellished with any literary drama. Also revealed are the positive actions of many people, and the mistakes and oversights of others. The book tries to bring the reader into the hospital rooms, where the reality of the... |
 |
Childhood Leukemia: Comprehensive New Approach to Treatment and Surviving Childhood Leukemia by Kelvin Yun (Author) |
 |
Walking with a Shadow: Surviving Childhood Leukemia by Nanci A. Sullivan (Author) Childhood cancer, particularly leukemia, is on the rise. Leukemia strikes one child in every 25,000, and most often does so between the ages of 3 and 7. Annually, more than 2,700 children are diagnosed with leukemia in the United States. Due to advances in biotechnology and medicine, survival rates for this once-deadly disease now stand at 80%. But the psychological effects of diagnosis, removal from school, treatment, and remission or cure, linger. Here nine long-term survivors of childhood leukemia share their vivid memories and give us insight into the physiological changes, psychosocial and educational difficulties that became a constant "shadow" in their lives. Author Nanci Sullivan provides recommendations for ways teachers, counselors and other professionals may better help young... |
 |
Love's 360 Fight Childhood Leukemia Key Chain by Love's 360 This fine key chain is a representation of your support to fight childhood leukemia. It is significant to me because this little girl who happens to be my niece passed away with it in 2007. |
![PRICELESS [CD on Demand]](http://ecx.images-amazon.com/images/I/51xj0x6M0-L._SL160_.jpg) |
PRICELESS [CD on Demand] by Jack Rodney Trevor's Song (Priceless) was written in honor of twelve-year-old Trevor Price's struggle and recorded in honor of his memory. All royalties will be donated to Children's Hospital, Seattle in hopes that this will help them find a cure for childhood leukemia and other childhood diseases. |
|
Childhood Leukemia, 3rd Edition [With Cancer Survivor's Treatment Record] [CHILDHOOD LEUKEMIA 3RD /E 3/E] [Paperback] by Nancy(Author) Keene (Author) | |
 |
DRIVE Season 1 Episode 4 "Unsung Heroes" Directed By: Build Worldwide |
| © 2009 BrightSurf.com |